Back to Agenda
Improving Investigative Site Selection Practices
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development, Tufts University School of Medicine, United States
Advancing a Data-Driven Foundation for Investigative Site and Country Selection Strategies
Learning Objective : Review data characterizing the changing global investigative site landscape; Assess site characteristics that are predictive of clinical trial performance; Discuss the attributes and anticipated value of Investigator Databank.
Speaker(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development, Tufts University School of Medicine, United States
Anticipating Trends and Changes in the Fragmented Global Investigative Site Landscape
Shawn Tedman, MBA
VP, Biopharma Innovation, ixlayer, United States
Advancing a Data-Driven Foundation for Investigative Site and Country Selection Strategies
Elisa Cascade, MBA
Chief Product Officer, Advarra, United States
Investigator Databank Collaboration: A Global Platform for Precompetitive Sharing
Have an account?